Keyphrases
Lung Transplantation
100%
Everolimus
100%
Randomised Double-blind Clinical Trial
100%
Acute Rejection
33%
Bronchiolitis Obliterans Syndrome
33%
Forced Expiratory Volume in 1 Second (FEV1)
22%
%FEV1
22%
Corticosteroids
11%
Lung Function
11%
Progression Rate
11%
Adverse Events
11%
Serum Creatinine
11%
Serious Adverse Events
11%
Cyclosporine
11%
Immunosuppressive Activity
11%
Graft Loss
11%
Maintenance Treatment
11%
Treatment Discontinuation
11%
Proliferation Signal Inhibitors
11%
Loss-to-follow-up
11%
AZA1
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Azathioprine
100%
Everolimus
100%
Syndrome
33%
Bronchiolitis Obliterans
33%
Adverse Event
22%
Acute Graft Rejection
22%
Immunosuppressive Agent
11%
Ciclosporin
11%
Chronic Graft Rejection
11%
Graft Failure
11%
Creatinine
11%
Immunology and Microbiology
Azathioprine
100%
Lung Transplantation
100%
Everolimus
100%
Bronchiolitis
33%
Acute Graft Rejection
22%
Immunosuppressive Drug
11%
Ciclosporin
11%
Chronic Graft Rejection
11%
Creatinine Blood Level
11%
Forced Expiratory Volume
11%